237 related articles for article (PubMed ID: 10188880)
1. Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin.
Cemazar M; Miklavcic D; Scancar J; Dolzan V; Golouh R; Sersa G
Br J Cancer; 1999 Mar; 79(9-10):1386-91. PubMed ID: 10188880
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of bioreductive drug tirapazamine is increased by application of electric pulses in SA-1 tumours in mice.
Cemazar M; Parkins CS; Holder AL; Kranjc S; Chaplin DJ; Sersa G
Anticancer Res; 2001; 21(2A):1151-6. PubMed ID: 11396155
[TBL] [Abstract][Full Text] [Related]
3. Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats.
Tozon N; Sersa G; Cemazar M
Anticancer Res; 2001; 21(4A):2483-8. PubMed ID: 11724311
[TBL] [Abstract][Full Text] [Related]
4. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin.
Sersa G; Krzic M; Sentjurc M; Ivanusa T; Beravs K; Kotnik V; Coer A; Swartz HM; Cemazar M
Br J Cancer; 2002 Oct; 87(9):1047-54. PubMed ID: 12434299
[TBL] [Abstract][Full Text] [Related]
5. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy.
Cemazar M; Parkins CS; Holder AL; Chaplin DJ; Tozer GM; Sersa G
Br J Cancer; 2001 Feb; 84(4):565-70. PubMed ID: 11207055
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
Cemazar M; Pipan Z; Grabner S; Bukovec N; Sersa G
Anticancer Res; 2006; 26(3A):1997-2002. PubMed ID: 16827135
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice.
Sersa G; Cemazar M; Miklavcic D
Cancer Res; 1995 Aug; 55(15):3450-5. PubMed ID: 7614485
[TBL] [Abstract][Full Text] [Related]
8. Tumor blood flow modifying effect of electrochemotherapy with bleomycin.
Sersa G; Cemazar M; Miklavcic D; Chaplin DJ
Anticancer Res; 1999; 19(5B):4017-22. PubMed ID: 10628347
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
10. Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients.
Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z
Clin Cancer Res; 2000 Mar; 6(3):863-7. PubMed ID: 10741708
[TBL] [Abstract][Full Text] [Related]
11. Antitumour effectiveness of hyperthermia is potentiated by local application of electric pulses to LPB tumours in mice.
Karner KB; Lesnicar H; Cemazar M; Sersa G
Anticancer Res; 2004; 24(4):2343-8. PubMed ID: 15330182
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of perianal tumors in dogs with electrochemotherapy.
Tozon N; Kodre V; Sersa G; Cemazar M
Anticancer Res; 2005; 25(2A):839-45. PubMed ID: 15868917
[TBL] [Abstract][Full Text] [Related]
13. Electrochemotherapy with cisplatin in the treatment of tumor cells resistant to cisplatin.
Cemazar M; Sersa G; Miklavcic D
Anticancer Res; 1998; 18(6A):4463-6. PubMed ID: 9891510
[TBL] [Abstract][Full Text] [Related]
14. Electroporation of LPB sarcoma cells in vitro and tumors in vivo increases the radiosensitizing effect of cisplatin.
Kranjc S; Cemazar M; Grosel A; Scancar J; Sersa G
Anticancer Res; 2003; 23(1A):275-81. PubMed ID: 12680224
[TBL] [Abstract][Full Text] [Related]
15.
Kranjc S; Cemazar M; Sersa G; Scancar J; Grabner S
Radiol Oncol; 2017 Sep; 51(3):295-306. PubMed ID: 28959166
[TBL] [Abstract][Full Text] [Related]
16. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases.
Sersa G; Stabuc B; Cemazar M; Miklavcic D; Rudolf Z
Melanoma Res; 2000 Aug; 10(4):381-5. PubMed ID: 10985673
[TBL] [Abstract][Full Text] [Related]
17. Metastatic potential of melanoma cells is not affected by electrochemotherapy.
Todorovic V; Sersa G; Mlakar V; Glavac D; Flisar K; Cemazar M
Melanoma Res; 2011 Jun; 21(3):196-205. PubMed ID: 20216102
[TBL] [Abstract][Full Text] [Related]
18. Effects of electrochemotherapy on CaSki cells derived from a cervical squamous cell carcinoma.
Yabushita H; Yoshikawa K; Hirata M; Furuya H; Hojyoh T; Fukatsu H; Noguchi M; Nakanishi M
Gynecol Oncol; 1997 May; 65(2):297-303. PubMed ID: 9159341
[TBL] [Abstract][Full Text] [Related]
19. EPR oximetry of tumors in vivo in cancer therapy.
Sentjurc M; Cemazar M; Sersa G
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1379-85. PubMed ID: 15134738
[TBL] [Abstract][Full Text] [Related]
20. Electrochemotherapy in treatment of tumours.
Sersa G; Miklavcic D; Cemazar M; Rudolf Z; Pucihar G; Snoj M
Eur J Surg Oncol; 2008 Feb; 34(2):232-40. PubMed ID: 17614247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
